Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
基本信息
- 批准号:7561648
- 负责人:
- 金额:$ 36.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAgonistAllergicAspirinAsthmaBiologicalBiological AssayBronchial SpasmChronicChronic SinusitisCloningDataDiseaseElectrophoretic Mobility Shift AssayEndotheliumEpitheliumFeedbackFibrosisGenesGenetic TranscriptionGlandGrantHyperplasiaIndividualInflammationInflammatoryInterleukin-13Interleukin-4InterleukinsInvestigationKnockout MiceLeukotrienesLung diseasesMediatingMolecularMucous body substanceNasal PolypsOccupationsPathway interactionsProceduresProcessProductionReactionRegulationReportingResearch PersonnelRoleSignaling ProteinSinusitisSiteSyndromeTherapeuticTranscriptional RegulationUp-RegulationWorkairway remodelingbasecysteinyl leukotriene receptor 2cysteinyl-leukotrienecytokinedesensitizationeffective therapyeosinophilhuman IRS2 proteinin vivoleukotriene-C4 synthasepromoterreceptorreceptor expressionrespiratory smooth muscletranscription factor
项目摘要
This grant will investigate the pro-inflammatory feedback reaction that develops between interleukin (IL)-4
(and other cytokines) and cysteinyl leukotrienes (CysLTs) that leads to the inflammation, hyperplasia, and
airway remodeling observed in chronic hyperplastic eosinophilic sinusitis (CHES) and asprin-exacerbated
respiratory disease (AERD). AERD is a syndrome characterized by severe persistent asthma, aggressive
airway remodeling, extensive hyperplastic eosinophilic sinusitis with nasal polyp (NP) formation, and
intolerance to aspirin. Eosinophils are essential to the fibrotic processes associated with asthma and CHES.
Aspirin intolerance reflects increased expression of leukotriene C4 synthase (LTC4S) and CysLT receptor
expression and, as a result, these subjects have constitutive overproduction and heightened responsiveness
to CysLTs. CysLTs function through their ability to interact with two homologous receptors: CysLTI and
CysLT2 both of which are highly upregulated in AERD. We hypothesize that CysLTs contribute to the
hyperplasia, fibrosis, and remodeling of AERD through their activation of eosinophils. Both the pathway
responsible for CysLT synthesis and the expression of CysLT receptors are tightly regulated by cytokines,
including prominently, IL-4. This pro-inflammatory feedback between CysLTs and IL-4 promotes eosinophil-
mediated inflammation, mucus gland secretion, and the proliferation of airway smooth muscle, epithelium,
and endothelium, leading to fibrosis. In specific aim #1 we will dissect individual roles for CysLTI and
CysLT2 receptors in these processes. Our hypothesis is that whereas the CysLTI receptor may be uniquely
involved in bronchospasm, the upregulation of CysLT2 receptor-dependent pathways has more important
remodeling functions in CHES/AERD. Specific aim #2 will investigate the regulation of CysLT receptors and
LTC4S expression by IL-4. Finally, aspirin desensitization is an effective treatment for AERD. Therefore
specific aim #3 will investigate the role of IL-4 antagonism by aspirin as the therapeutic basis for the efficacy
of this procedure
该基金将研究白细胞介素-4(IL-4)与炎症反应之间的促炎反馈反应。
(and其他细胞因子)和半胱氨酰白三烯(CysLT),其导致炎症、增生和
在慢性增生性嗜酸性鼻窦炎(CHES)中观察到气道重塑,
呼吸系统疾病(AERD)。AERD是一种以严重的持续性哮喘、侵袭性哮喘、呼吸道感染和哮喘发作为特征的综合征。
气道重塑,广泛增生性嗜酸性鼻窦炎伴鼻息肉(NP)形成,
阿司匹林不耐受嗜酸性粒细胞在与哮喘和CHES相关的纤维化过程中是必不可少的。
阿司匹林不耐受反映了白三烯C4合酶(LTC 4S)和CysLT受体表达增加
因此,这些受试者具有结构性过度生产和高度反应性
到CysLT CysLT通过其与两种同源受体相互作用的能力发挥作用:CysLTI和CysLTI。
CysLT 2两者在AERD中均高度上调。我们假设CysLTs有助于
增生、纤维化和通过嗜酸性粒细胞活化的AERD重塑。这两种途径
负责CysLT合成和CysLT受体的表达受到细胞因子的严格调节,
主要包括IL-4。CysLTs和IL-4之间的这种促炎反馈促进嗜酸性粒细胞-
介导的炎症,粘液腺分泌,和气道平滑肌,上皮,
和内皮细胞,导致纤维化在具体目标1中,我们将剖析CysLTI的个体作用,
这些过程中的CysLT 2受体。我们的假设是,虽然CysLTI受体可能是唯一的
在支气管痉挛中,CysLT 2受体依赖性途径的上调具有更重要的意义。
CHES/AERD中的重塑功能。具体目标#2将研究CysLT受体的调节,
通过IL-4表达LTC 4S。最后,阿司匹林脱敏是AERD的有效治疗方法。因此
具体目标#3将研究阿司匹林的IL-4拮抗作用作为疗效的治疗基础
本程序
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARRY C BORISH其他文献
LARRY C BORISH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARRY C BORISH', 18)}}的其他基金
Protracted clinical and inflammatory response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的持久临床和炎症反应
- 批准号:
10540527 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Clinical response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床反应
- 批准号:
9893778 - 财政年份:2016
- 资助金额:
$ 36.08万 - 项目类别:
Clinical response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床反应
- 批准号:
9081696 - 财政年份:2016
- 资助金额:
$ 36.08万 - 项目类别:
Clinical immune response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床免疫反应
- 批准号:
9075457 - 财政年份:2015
- 资助金额:
$ 36.08万 - 项目类别:
CD4+ and CD8+ T cell dependent immune mechanisms of rhinovirus-mediated asthma ex
鼻病毒介导的哮喘的 CD4 和 CD8 T 细胞依赖性免疫机制
- 批准号:
8077929 - 财政年份:2010
- 资助金额:
$ 36.08万 - 项目类别:
CD4+ and CD8+ T cell dependent immune mechanisms of rhinovirus-mediated asthma ex
鼻病毒介导的哮喘的 CD4 和 CD8 T 细胞依赖性免疫机制
- 批准号:
7975934 - 财政年份:2010
- 资助金额:
$ 36.08万 - 项目类别:
Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
- 批准号:
7167443 - 财政年份:2006
- 资助金额:
$ 36.08万 - 项目类别:
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i
LTE4/LTE4 受体和 IFN-γ 与肥大细胞和嗜酸性粒细胞之间的相互作用
- 批准号:
8450125 - 财政年份:2006
- 资助金额:
$ 36.08万 - 项目类别:
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i
LTE4/LTE4 受体和 IFN-γ 与肥大细胞和嗜酸性粒细胞之间的相互作用
- 批准号:
8259134 - 财政年份:2006
- 资助金额:
$ 36.08万 - 项目类别:
Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
- 批准号:
7761238 - 财政年份:2006
- 资助金额:
$ 36.08万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 36.08万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 36.08万 - 项目类别:














{{item.name}}会员




